Abstract
Bioactive sphingolipids are a lipid family including ceramide, sphingosine-1-phosphate (S1P) and glucosyl ceramide (GC). Ceramide produced through de novo synthesis pathway (Serine Palmitoyl Transferase (SPT) is a key enzyme subjected to regulation) plays significant roles in the induction of apoptosis. On the other hand, the conversion of ceramide into S1P and GC by sphingosine kinase 1 (SK-1) and glucosyl ceramide synthase (GCS) induce the proliferation of cancer cells. It is aimed to investigate therapeutic potential of resveratrol on Ph + ALL cells and to identify potential mechanisms behind resveratrol-mediated cytotoxicity in association with targeting of ceramide metabolism. The antiproliferative effects of resveratrol, SPT inhibitor (myriocin), SK-1 inhibitor (SKI II), GCS inhibitor (PDMP), resveratrol: SPT inhibitor, resveratrol: SK-1 inhibitor and resveratrol:GCS inhibitor combinations on SD-1 cells are investigated by cell proliferation assay. The combination indexes are calculated using Calcusyn program. There were synergistic cytotoxic effects of resveratrol with co-administration of myriocin, SK-1 inhibitor and GCS inhibitor. This preliminary data showed for the first time that resveratrol might inhibit the growth of Ph + ALL cells through targeting ceramide metabolism. Molecular studies are still undergoing to reveal the mechanisms behind this synergistic effects.
Acknowledgments
This project is supported by TUBITAK (project number 315S248).
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2017 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).